Clinical Trials Directory

Trials / Completed

CompletedNCT00512564

Clinical and Laboratory Assessment of Iron Overload in Sickle Cell Anemia and Sickle Cell Thalassemia

Clinical and Laboratory Assessment of Iron Overload in Sickle Cell Anemia and Sickle Cell Thalassemia - An Observational and Laboratory Study

Status
Completed
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
HaEmek Medical Center, Israel · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Iron overload is well study in Thalassemia patients and it's not only related to blood transfusions, since intestinal iron absorption is also increased in those patients. Sickle cell patients didn't developed significant clinical symptoms and signs of iron overload in spite frequent transfusions. The purpose of this study is to assess the iron overload in Sickle cell anemia and Sickle cell Thalassemia patients using clinical parameters and laboratory studies including Non Transferrin Binding Iron, Labile Iron and Hepcidin, in order to determine the cardiac and liver iron.

Conditions

Interventions

TypeNameDescription
OTHERLaboratory analyses of iron overloadSummary of clinical status related to iron overload and laboratory analysis of Iron overload including Total serum Iron, Transferrin, Ferritin and Non transferrin Binding Iron and Labile Plasma Iron

Timeline

Start date
2008-09-01
Primary completion
2010-12-01
Completion
2010-12-01
First posted
2007-08-07
Last updated
2011-08-26

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00512564. Inclusion in this directory is not an endorsement.